Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Agilent Technologies Inc. filings document financial reporting and governance matters for an analytical and clinical laboratory technology company. Form 8-K reports include quarterly financial-result releases, Regulation FD disclosures, non-GAAP measure explanations, executive officer transitions, compensatory arrangements and amendments to charter and bylaws.
Proxy and annual-meeting filings cover director elections, stockholder voting, executive compensation, equity awards and the phased declassification of the board. The records also identify governance changes tied to the company’s Delaware certificate of incorporation and bylaws, together with furnished press releases and related exhibits.
Agilent Technologies, Inc. reported an insider equity transaction by a Senior Vice President. On 11/26/2025, the executive surrendered 280 shares of common stock to Agilent to satisfy tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. The shares were valued at $154.37 each for this tax withholding transaction.
After this event, the executive beneficially owned 26,593.9266 shares of Agilent common stock directly and 2,607.6856 shares indirectly through a spouse. This is an administrative tax-related transaction rather than an open-market purchase or sale.
Agilent Technologies, Inc. reported an insider transaction by its President and CEO, who is also a director. On 11/26/2025, the executive surrendered 1,948 shares of common stock to Agilent at $154.37 per share to cover tax liabilities arising from the vesting of restricted stock units under Rule 16b-3.
After this tax-related share surrender, the executive beneficially owns 66,539 shares of Agilent common stock in direct ownership. This filing reflects a routine administrative transaction to satisfy taxes rather than an open-market sale.
Agilent Technologies, Inc. officer and Senior Vice President reported a routine equity transaction on Form 4. On 11/26/2025, the reporting person surrendered 300 shares of Agilent common stock to the company at a price of $154.37 per share to cover tax liabilities arising from the vesting of restricted stock units under Rule 16b-3. After this tax-related surrender, the reporting person beneficially owned 14,207.2469 shares of Agilent common stock, held directly.
Agilent Technologies executive reports small stock disposition for tax withholding
A Senior Vice President of Agilent Technologies, Inc. reported a routine share disposition related to equity compensation. On 11/26/2025, the executive surrendered 430 shares of Agilent common stock at a reported price of $154.37 per share, coded as an "F" transaction, meaning the shares were withheld to cover taxes on vesting restricted stock units. After this transaction, the executive beneficially owns 14,262 shares of Agilent common stock directly. No derivative securities transactions were reported in this filing.
Agilent Technologies executive Rodney Gonsalves, Vice President and Corporate Controller, reported multiple stock transactions in Agilent Technologies, Inc. common stock. On 11/26/2025, he sold 3,000 shares at a weighted average price of $154.9853 per share, with individual sale prices ranging from $154.98 to $155.05. He also surrendered 119 shares to Agilent to cover tax liabilities related to the vesting of restricted stock units.
That same day, Gonsalves reported several gift-related movements: transfers coded as gifts involving 200 shares connected to the Gonsalves Family Charitable Gift Fund and indirect holdings in the Gonsalves Trust. After these transactions, he directly owned 31,526.6872 shares of Agilent common stock and held 40.192 shares indirectly through the Gonsalves Trust.
Agilent Technologies reported an insider equity transaction by a senior vice president. On 11/26/2025, the executive surrendered 332 shares of Agilent common stock to the company to cover tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. The shares were valued at $154.37 each for this tax withholding transaction. After this adjustment, the reporting person directly beneficially owns 12,203.056 shares of Agilent common stock.
Agilent Technologies (A) filed a Form 144 indicating a planned sale of 3,000 shares of its common stock through Fidelity Brokerage Services LLC on 11/26/2025 on the NYSE, with an aggregate market value of 464,956.00. The notice states that the issuer had 283,500,427 shares of common stock outstanding, providing context for the size of the planned sale.
The shares to be sold were acquired over time through employee stock purchase plan (ESPP) purchases made for cash and through restricted stock that vested as compensation between 10/31/2022 and 11/22/2024. The person selling represents that they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.
Agilent Technologies, Inc. (ticker: A) reported an insider equity transaction by a Senior Vice President. On 11/21/2025, the executive surrendered 67 shares of Agilent common stock to the company at a price of $151.25 per share. This was done to cover tax liabilities arising from the vesting of restricted stock units under Rule 16b-3, which governs certain insider transactions. After this tax-related share surrender, the executive beneficially owned about 11,847.0318 shares of Agilent common stock directly.
Agilent Technologies, Inc. (A) reported an insider transaction by a Senior Vice President. On 11/21/2025, the executive surrendered 75 shares of common stock to Agilent Technologies, Inc. to cover tax liabilities arising from the vesting of restricted stock units, as allowed under Rule 16b-3. After this tax withholding, the executive directly beneficially owned 26,873.9266 shares of common stock and indirectly owned 2,607.6856 shares through a spouse.
Agilent Technologies, Inc. (ticker: A) reported an insider equity transaction by its President and CEO, who is also a director. On 11/21/2025, the executive surrendered 541 shares of common stock to Agilent at a price of $151.25 per share.
The filing explains that these shares were surrendered to the company to satisfy tax liabilities arising from the vesting of restricted stock units under Rule 16b-3. After this tax-related share surrender, the executive directly beneficially owns 68,487 shares of Agilent common stock.